Skip to content

The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear

The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05497934
Enrollment
0
Registered
2022-08-11
Start date
2022-10-01
Completion date
2024-03-31
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tympanosclerosis, Thickened Ears, Healthy, Surgery

Brief summary

This study will examine the improvement in middle ear optical coherence tomography imaging from the topical application of glycerol to the tympanic membrane in normal, opaque and post-operative ears

Detailed description

This study will explore whether the utility of Optical Coherence Tomography (OCT) in otology patients can be enhanced through the application of topical glycerol as an optical clearing agent in patients with normal, opaque and post operative tympanic membranes. In each group of subjects, a comparison will be made between OCT images obtained before and after the topical application of glycerol to the tympanic membrane and following washout with saline. Images will also be assessed for their diagnostic utility as determined by the visibility of key structures and the change in middle ear mobility caused by glycerol absorption in the tympanic membrane.

Interventions

In this study, 99.5% pure glycerol will be used as an optical clearing agent. The glycerol will be applied topically to the tympanic membrane.

Sponsors

Dalhousie University
CollaboratorOTHER
Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

All subjects will undergo OCT and conventional endoscopic imaging before topical application of glycerol to the tympanic membrane, after topical application of glycerol to the tympanic membrane and after rinsing the tympanic membrane with saline.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Thickened tympanic membrane (e.g. due to fibrosis) x10 * Tympanosclerosis of the tympanic membrane x10 * History of middle ear surgery with partial or total ossicular replacement prosthesis and cartilage tympanoplasty x10 * History of cartilage tympanoplasty without prosthesis implantation x10 * Normal tympanic membrane without history of middle ear disease x10

Exclusion criteria

* Narrow or stenotic external auditory canal that prevents visualization of the tympanic membrane * Mobility disorder that prevents patient from remaining still during imaging * Perforation of the tympanic membrane * Open sores or infections of the external auditory canal

Design outcomes

Primary

MeasureTime frameDescription
Change in optical attenuation rate of the tympanic membrane20 minutesChange in optical attenuation rate (dB/mm) of the tympanic membrane between the pre-treatment and post-treatment conditions

Secondary

MeasureTime frameDescription
Change in acoustic mobility of the umbo20 minutesChange in the mobility (mm/s/Pa) of the umbo between pre- and post-treatment conditions
Change in B-mode signal-to-noise ratio of the cochlear promontorium20 minutesChange in the B-mode signal-to-noise ratio for a region of interest on the cochlear promontorium distal to the tympanic membrane between pre- and post-treatment conditions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026